HyFect® Transfection Reagent

Katalognummer

LDG0001RA

Datenblatt

Weitere Dokumente

Paket & Preis werden geladen...

COA-Suche

• Übersicht

  Beschreibung

  HyFect® Transfection Reagent is a low cell toxicity and non-liposome reagent optimized for DNA delivery. It provides effectively, reproducibly, and affordable benefits for scientific research.

• Spezifikationen

  • Anwendung

    Cell transfection

    Probentyp

    Adherent cells | Suspension cells

• Anleitung

  • Versand

    The product is shipped with polar packs. Upon receipt, store it immediately at -20°C or lower for long term storage.

    Stabilität & Lagerung

    This product is stable after storage at:

    • -20°C or -80°C for 12 months under sterile conditions from date of receipt.

    Avoid repeated freeze/thaw cycles.

• Bild

  Transfection: Cells were transfected with 500 ng of GFP mRNA (left) or mCherry plasmid (right) using two different transfection reagents. The upper row shows results using HyFect® Transfection Reagent (LDG0001RA), with strong fluorescence for mCherry, indicating high transfection efficiency for plasmid. The lower row shows results using HyFect® mRNA-Xpert Transfection Reagent (LDG0003RA), which exhibits significantly stronger GFP (green) fluorescence. Bright-field images are shown alongside fluorescence images to visualize cell morphology.

  1

  /

  1

  Gesamt   (1)

• Bewertung

  

  Helfen Sie anderen, mehr über dieses Produkt zu erfahren. Nutzen Sie den Link unten, um Ihre Erfahrung zu teilen.

  Bewertung abgeben

• Publikation

  1. Lin YM et al. Biochem Biophys Res Commun. 2022; 630:151-157.
  2. Hung YH et al. Int J Mol Sci. 2022; 23(5):2608.
  3. Yang YH et al. Viruses. 2022; 14(5):925.
  4. Hung YH et al. American journal of cancer research. 2022; 12(2):713-728.
  5. Cheng YW et al. Journal of Biomedical Science. 2022; 29(1):10.
  6. Li JN et al. Front Cell Dev Biol. 2021; 9:671244.
  7. Chang YH et al. PLoS One. 2021; 16(7):e0254011.
  8. Lin YM et al. Biochem Biophys Res Commun . 2021; 542:59-64.
  9. Zhu D et al. Exp Ther Med. 2021; 21(1):17.
  10. Li JN et al. Cancers (Basel). 2021; 13(24):6304.
  11. Lin LC et al. Int J Med Sci. 2020; 17(14):2214-2224.
  12. Pinals RL et al. medRxiv. 2020.
  13. Xue J et al. Oncol Lett. 2020; 19(2):1255-1260.
  14. Chen PS et al. US patent application. 2019.
  15. Wu YH et al. Cell Death Dis. 2019; 10(4):322.
  16. Wang HC et al. Theranostics. 2019; 9(24):7168-7183.
  17. Wang MY et al. Cancers (Basel). 2019; 11(2):210.
  18. Lai HH et al. Mol Oncol. 2019; 13(4):928-945.
  19. Hung WY et al. Cell Physiol Biochem. 2018; 51(1):337-355.
  20. Lai HH et al. Biochem Biophys Res Commun. 2018; 506(1):87-93.
  21. Huang YF et al. Clin Cancer Res. 2018; 24(13):3217-3228.
  22. Chao CH et al. Shock. 2018; 50(1):103-111.
  23. Lai YC et al. Antiviral Res. 2018; 155:28-38.
  24. Wu YH et al. Int J Cancer. 2017; 141(11):2305-2317.
  25. Dai YH et al. Transl Res. 2016; 175:129-143.
  26. Lai YC et al. Cell Death Dis. 2015; 6(12):e2008.
  27. Chen HR et al. Biol Open. 2015; 4(2):244-52.

  Weitere Publikationen

  Weniger Publikationen

  Publikation einreichen

• Datenblatt & Dokumente

  Datenblatt

  MSDS

  Handbuch

  1

  /

  2

Haftungsausschluss：For Research Use or Further Manufacturing Only.